Fatigue News and Research

RSS

Phase 2 trial shows COVID-19 recombinant protein vaccine elicits promising immunogenicity responses

Researchers performed a large-scale, double-blind, placebo-controlled phase two trial to assess the efficacy, safety, and immune response elicited from vaccination with MVC-COV1901.

19 Oct 2021

People with higher genetic risk for clinical depression more likely to experience physical symptoms

People with higher genetic risk of clinical depression are more likely to have physical symptoms such as chronic pain, fatigue and migraine, University of Queensland researchers have found.

18 Oct 2021

Mix-and-match booster shots beneficial in boosting SARS-CoV-2 immunity

Should you get a second dose of the same vaccine if you’ve received the one-dose Johnson & Johnson shot? According to new clinical trial results published on the preprint medRxiv* server, a booster shot of a messenger RNA (mRNA) vaccine may increase your chances of neutralizing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).

17 Oct 2021

Researchers identify common side effects of three COVID-19 vaccines

COVID-19 vaccines remain the best tool in the pandemic toolbox against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). But they are not perfect; reports have surfaced of mild to severe side effects after vaccination. A new study from researchers in the Lampe & Company GmbH & Co. KG compared the severity of adverse events from each coronavirus vaccine.

17 Oct 2021

Phase 1 open-label trial shows SARS-CoV-2 DNA vaccine induces durable immune response

The efficacy and safety of a DNA-based vaccine are investigated, finding that the unique vaccine imparts a robust and long-lasting immunogenic response.

15 Oct 2021

Study finds menstrual bleeding changes after SARS-CoV-2 vaccination

A new study investigated menstrual bleeding patterns among current and former menstruating people, based on the premise that these bleeding changes were associated with changes in clotting or inflammation, which can affect the normal menstrual repair.

15 Oct 2021

Study finds relatively low rate of COVID-19 infection following full vaccination in North Carolina

A recent study seeks to investigate the characteristics of individuals with breakthrough infections post-vaccination in North Carolina, USA.

14 Oct 2021

More than half of COVID-19 survivors experience "long COVID", researchers say

More than half of the 236 million people who have been diagnosed with COVID-19 worldwide since December 2019 will experience post-COVID symptoms - more commonly known as "long COVID" - up to six months after recovering, according to Penn State College of Medicine researchers.

13 Oct 2021

Many breast cancer patients use cannabis without the knowledge of physicians

New research indicates that almost half of U.S. adults with breast cancer use cannabis (marijuana and hemp), most commonly alongside cancer treatment to manage symptoms and side effects.

12 Oct 2021

Novel vaccine demonstrates high efficacy for prevention of COVID-19

The clinical trial studied the efficacy of Novavax’s COVID-19 vaccine, NVX-CoV2373, and found it highly effective in preventing mild, moderate, and severe COVID-19 after full vaccination.

12 Oct 2021

Delta SARS-CoV-2 variant does not make kids sicker than Alpha, study finds

Children are not at risk for more severe COVID-19 disease with Delta compared to earlier severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variants, finds a new medRxiv* preprint study. In the first large-scale epidemiological study comparing SARS-CoV-2 infection between variants in children, researchers found children were more likely to be as sick from Delta as they would be if they were infected with the Alpha variant.

11 Oct 2021

Mandatory masking resulted in lower rate of COVID-19 infection among school children

A masking mandate in North Carolina schools during the early weeks of the Delta variant surge resulted in a lower rate of infection among school children and staff members than what was reported in the broader community, according to a new report from the ABC Science Collaborative.

11 Oct 2021

The neurological effects of COVID-19

What is the relationship between COVID-19 and the brain? A new review published in Tropical Biomedicine summarizes the key findings on how severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes severe COVID-19 infection, disrupts brain activity and produces a range of long-term neurological disorders.

10 Oct 2021

Scientists elucidate the structure of protein complex essential for proper functioning of cells

Scientists at IST Austria describe for the first time the structure of a protein complex essential for our cells to function properly.

7 Oct 2021

Psychological therapy alleviates adverse biobehavioral effects in young adult testicular cancer survivors

Psychological therapy reduces the adverse biobehavioral effects of testicular cancer in young adult survivors, according to a pilot study led by the University of California, Irvine.

6 Oct 2021

Moderna COVID vaccine booster dose results in immune memory

A recent study presents evidence that a booster dose of the Moderna vaccine can induce a robust memory immune response against COVID-19.

6 Oct 2021

Gene expression changes during acute SARS-CoV-2 infection may decide long-COVID symptoms

A team of US-based scientists has recently revealed the changes in gene expression profiles associated with the long-term consequences of COVID-19.

6 Oct 2021

Health-related quality of life of COVID-19 patients with long-COVID: Study

Researchers conducted a survey-based study and assessed the impact of long COVID on the health-related quality of life in Japanese COVID-19 patients.

4 Oct 2021

Post-COVID depressive symptoms respond well to antidepressants, study shows

The COVID pandemic has led to a significant increase in mental health problems. Now, in some good news, a pilot study has shown that depressed patients who have suffered from COVID respond better to standard antidepressants than do people who have not had COVID.

4 Oct 2021

Online searches for arthritis symptoms increase among UK residents

Online searches for symptoms of arthritis and osteoarthritis increase with residents throughout the UK.

4 Oct 2021

Fatigue News and Research

Phase 2 trial shows COVID-19 recombinant protein vaccine elicits promising immunogenicity responses

People with higher genetic risk for clinical depression more likely to experience physical symptoms

Mix-and-match booster shots beneficial in boosting SARS-CoV-2 immunity

Researchers identify common side effects of three COVID-19 vaccines

Phase 1 open-label trial shows SARS-CoV-2 DNA vaccine induces durable immune response

Study finds menstrual bleeding changes after SARS-CoV-2 vaccination

Study finds relatively low rate of COVID-19 infection following full vaccination in North Carolina

More than half of COVID-19 survivors experience "long COVID", researchers say

Many breast cancer patients use cannabis without the knowledge of physicians

Novel vaccine demonstrates high efficacy for prevention of COVID-19

Delta SARS-CoV-2 variant does not make kids sicker than Alpha, study finds

Mandatory masking resulted in lower rate of COVID-19 infection among school children

The neurological effects of COVID-19

Scientists elucidate the structure of protein complex essential for proper functioning of cells

Psychological therapy alleviates adverse biobehavioral effects in young adult testicular cancer survivors

Moderna COVID vaccine booster dose results in immune memory

Gene expression changes during acute SARS-CoV-2 infection may decide long-COVID symptoms

Health-related quality of life of COVID-19 patients with long-COVID: Study

Post-COVID depressive symptoms respond well to antidepressants, study shows

Online searches for arthritis symptoms increase among UK residents

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News